Offer - Urjas Oil for just ₹ 1 X
Sitara M 100/1000 Tablet ER (10) is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Sitara M 100/1000 Tablet ER (10) safe for pregnant women?
Pregnant women may get mild side effects from Sitara M Tablet.
Is the use of Sitara M 100/1000 Tablet ER (10) safe during breastfeeding?
Breastfeeding women may feel side effects of Sitara M Tablet. If you see any side effects, stop taking Sitara M Tablet immediately and talk to your doctor. Take Sitara M Tablet again, only after your doctor's advice.
What is the effect of Sitara M 100/1000 Tablet ER (10) on the Kidneys?
Sitara M Tablet is not harmful for kidneys.
What is the effect of Sitara M 100/1000 Tablet ER (10) on the Liver?
Sitara M Tablet is not harmful for the liver.
What is the effect of Sitara M 100/1000 Tablet ER (10) on the Heart?
Sitara M Tablet is not harmful for the heart.
If you are suffering from any of the following diseases, you should not take Sitara M 100/1000 Tablet ER (10) unless your doctor advises you to do so -
Is this Sitara M 100/1000 Tablet ER (10) habit forming or addictive?
Sitara M 100/1000 Tablet ER (10) does not cause addiction.
Interaction between Food and Sitara M 100/1000 Tablet ER (10)
Due to the absence of research, it is difficult to say how Sitara M 100/1000 Tablet ER (10) and food will interact.
Interaction between Alcohol and Sitara M 100/1000 Tablet ER (10)
Consuming Sitara M 100/1000 Tablet ER (10) with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Januvia® (sitagliptin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 274-275
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1143-1144
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826